Última Hora: "Infante. Vem aí o primeiro satélite criado em Portugal - Diário de Notícias - Lisboa" Wed, 18 Oct 2017 21:54:00 GMT    "Novo Banco coloca PME como prioridade - Dinheiro Vivo" Thu, 19 Oct 2017 16:22:52 GMT    "Comércio entre Macau e países lusófonos com "dimensão frustrante" -- economista - Diário de Notícias - Lisboa" Sat, 21 Oct 2017 08:05:00 GMT    "Cerca de 3,6 milhões de pensões aumentadas em janeiro - Observador" Fri, 20 Oct 2017 16:56:00 GMT    "Governo de Passos suspeito de corrupção na Operação Marquês - Público.pt" Wed, 18 Oct 2017 05:38:08 GMT    "TAP vai contratar 400 para abrir novas rotas. E não só no Porto - Dinheiro Vivo" Fri, 20 Oct 2017 07:29:23 GMT   "Altice acusa NOS de não aceitar a livre concorrência como regra do jogo - Expresso" Fri, 20 Oct 2017 18:06:00 GMT    "Mota-Engil informa que a Lineas vendeu participações na SCUTVIAS e PORTVIAS - RTP" Fri, 20 Oct 2017 16:27:00 GMT    ""O Estado não se mete na gestão da TAP" - TSF Online" Sat, 21 Oct 2017 00:06:25 GMT    "Governo quer limites de captura de sardinha para Portugal e Espanha entre 13,5 e 14 mil toneladas - Observador" Fri, 20 Oct 2017 16:26:42 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Asthma Medication Market ? Global Industry Size, Growth Analysis, Trends, Demand and Segment Forecast To 2022
Medgadget (blog)
Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks ...

e mais »

ContraFect (CFRX) Names Lisa Ricciardi as COO
StreetInsider.com
... firms and biotechnology companies. Ms. Ricciardi currently serves on the board United Drug Healthcare Group, PLC, and was a prior board member Chimerix Inc. as well as Sepracor Inc., which was sold to Dainippon Sumitomo for $2.6 billion.

e mais »

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors
Business Wire (press release)
From 2007-2010, Mr. Koven served as Executive Vice President, General Counsel and Corporate Secretary at Sepracor Inc., where he was responsible for the company's legal and government affairs departments and Corporate Secretarial function until its ...

e mais »

Form 8-K Kala Pharmaceuticals, For: Sep 28
StreetInsider.com
On September 28, 2017, the Board of Directors (the ?Board?) of Kala Pharmaceuticals, Inc. (the ?Company?) increased the size of the Board from eight to nine directors and, following the recommendation of the Nominating and Corporate Governance ...


Belgium's Ablynx enters the US market
PMLiVE
Ablynx Belgium biopharmaceutical company Ablynx has established a beachhead in the US, setting up a new subsidiary for that market. Ablynx, Inc will be led by newly-appointed general manager Daniel Schneider, who will be based on the east coast.


Pediatric Internalizing Disorders: October 2017
Healio
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...


Asthma Medication Market Benefit and Volume 2017 with Status and Prospect to 2022
TS Global Market Updates (press release)
Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The new vendor entrants in the market are finding it hard to compete with the international vendors based on ...


Global Asthma Medication Market Outlook by Product Overview, Application and Regions 2022
satPRnews (press release)
This Report Provides in depth survey of Asthma Medication Market using various Market Research Analysis.It also provides the details about the major Key Players in the market based on the quality of the products,profiling and financial report of industry.

e mais »

Acer Therapeutics Appoints Dr. William T. Andrews as Chief Medical Officer
GlobeNewswire (press release)
CAMBRIDGE, Mass., Oct. 05, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc., (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet ...

e mais »

Desloratadine Market Demand Analysis by Experts 2017 To 2022
Otaku Reports
Companies Profiled in this report includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
Prior to HeartWare, Ms. Trevvett served in communications and investor relations roles at both Alkermes, Inc., a global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases, and Sepracor, ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Yahoo Finance
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with severe neurological diseases, today announced the appointment of William K. McVicar, Ph.D., as President of Research and Development. ... ?With ...

e mais »

Rewire

Religious Imposition Proponents Find an Ally in the White House
Rewire
Stirrup worked as a senior legislative adviser at Venable LLP from 2003 to 2008. The firm's clients between those years included AstraZeneca Pharmaceuticals, Sepracor Inc, and the National Association of Spine Specialists. Another hire, Anna Pilato, is ...


Reuters

Dainippon to buy US drug firm Sepracor for $2.6 billion
Reuters
It will also gain Sepracor's insomnia drug Lunesta, asthma drug Xopenex and an experimental epilepsy drug. ?We anticipate our business will shrink if we focus only on Japan, where medical prices are under pressure,? Dainippon Sumitomo President Masayo ...
Drugmaker Sepracor Accepts $2.6B Buyout Offer from Japan's DainipponXconomy

todos os 485 artigos de notícias »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters